{"id":"https://openalex.org/W7214614276","doi":"https://doi.org/10.64898/2026.09.21.751493","title":"A low-matrix organoid-T cell co-culture platform for functional evaluation of T cell engagers in patient-derived colorectal cancer organoids","display_name":"A low-matrix organoid-T cell co-culture platform for functional evaluation of T cell engagers in patient-derived colorectal cancer organoids","publication_year":2026,"publication_date":"2026-09-27","ids":{"openalex":"https://openalex.org/W7214614276","doi":"https://doi.org/10.64898/2026.09.21.751493"},"language":"en","primary_location":{"id":"doi:10.64898/2026.09.21.751493","doi":"https://doi.org/10.64898/2026.09.21.751493","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.21.751493","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/27/2026.09.21.751493.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"volume":null,"type":"preprint","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/27/2026.09.21.751493.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036768601","display_name":"Claudia Maria Assunta Pinna","orcid":"https://orcid.org/0000-0002-5618-7842","observed_orcids":["https://orcid.org/0000-0002-5618-7842"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Claudia M. A. Pinna","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK"],"raw_orcid":"https://orcid.org/0000-0002-5618-7842","affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114320757","display_name":"Kamila Rakhimova","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kamila Rakhimova","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","Department of Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Department of Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK","institution_ids":["https://openalex.org/I1308923049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146072588","display_name":"Jing Zhang","orcid":"https://orcid.org/0009-0003-5039-5688","observed_orcids":["https://orcid.org/0009-0003-5039-5688"]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jing Zhang","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5146033449","display_name":"Laura Bills","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura Bills","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152402615","display_name":"Louise Tee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Louise Tee","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152376981","display_name":"Charlotte Blanc","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Charlotte Blanc","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018418926","display_name":"David G. Millar","orcid":"https://orcid.org/0000-0002-0104-9303","observed_orcids":["https://orcid.org/0000-0002-0104-9303"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David G. Millar","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Waltham, MA, 02451, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Waltham, MA, 02451, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083552512","display_name":"Elsa Rottoli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elsa Rottoli","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011243856","display_name":"Ois\u00edn Huhn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ois\u00edn Huhn","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152371020","display_name":"Miguel Gaspar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Miguel Gaspar","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031918008","display_name":"Neeraj Lal","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Neeraj Lal","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","Department of Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Department of Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK","institution_ids":["https://openalex.org/I1308923049"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5153243673","display_name":"Romain Lara","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Romain Lara","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5152350151","display_name":"Kaitlin A. Marley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Kaitlin A. Marley","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087503746","display_name":"Sa\u0161o \u010cemerski","orcid":"https://orcid.org/0000-0001-7240-4600","observed_orcids":["https://orcid.org/0000-0001-7240-4600"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Saso Cemerski","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Waltham, MA, 02451, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Waltham, MA, 02451, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073399228","display_name":"Simon J. Dovedi","orcid":"https://orcid.org/0000-0003-0486-1206","observed_orcids":["https://orcid.org/0000-0003-0486-1206"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon J. Dovedi","raw_affiliation_strings":["AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, DICE, Early Oncology R&D, Cambridge Biomedical Campus, Cambridge, CB2 0AA, UK","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5044152755","display_name":"Andrew David Beggs","orcid":"https://orcid.org/0000-0003-0784-2967","observed_orcids":["https://orcid.org/0000-0003-0784-2967"]},"institutions":[{"id":"https://openalex.org/I1308923049","display_name":"University Hospitals Birmingham NHS Foundation Trust","ror":"https://ror.org/014ja3n03","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Andrew D. Beggs","raw_affiliation_strings":["Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","Department of Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"],"raw_orcid":"https://orcid.org/0000-0003-0784-2967","affiliations":[{"raw_affiliation_string":"Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Department of Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK","institution_ids":["https://openalex.org/I1308923049"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5036768601"],"corresponding_institution_ids":["https://openalex.org/I79619799"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.4077000021934509,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.2734000086784363,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.10140000283718109,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9279999732971191},{"id":"https://openalex.org/keywords/patient-derived-organoids","display_name":"patient-derived organoids","score":0.7929999828338623},{"id":"https://openalex.org/keywords/t-cell-engagers","display_name":"T-cell engagers","score":0.9789999723434448},{"id":"https://openalex.org/keywords/bispecific-t-cell-engagers","display_name":"bispecific T-cell engagers","score":0.9309999942779541},{"id":"https://openalex.org/keywords/tumor-immune-interactions","display_name":"tumor-immune interactions","score":0.699999988079071},{"id":"https://openalex.org/keywords/t-cell-activation","display_name":"T cell activation","score":0.6510000228881836},{"id":"https://openalex.org/keywords/ifn-gamma-secretion","display_name":"IFN-gamma secretion","score":0.8899999856948853},{"id":"https://openalex.org/keywords/interpatient-heterogeneity","display_name":"interpatient heterogeneity","score":0.7940000295639038}],"concepts":[{"id":"https://openalex.org/C31695470","wikidata":"https://www.wikidata.org/wiki/Q11293125","display_name":"Organoid","level":2,"score":0.907800018787384},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.5188999772071838},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5055000185966492},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.484499990940094},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.46470001339912415},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.46459999680519104},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4343999922275543},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4115999937057495},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.38109999895095825},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.3587999939918518},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34700000286102295},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.33559998869895935},{"id":"https://openalex.org/C53227056","wikidata":"https://www.wikidata.org/wiki/Q189152","display_name":"Viability assay","level":3,"score":0.320499986410141},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.3183000087738037},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3050000071525574},{"id":"https://openalex.org/C174510640","wikidata":"https://www.wikidata.org/wiki/Q489618","display_name":"HEK 293 cells","level":3,"score":0.299699991941452},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.2953000068664551},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.29339998960494995},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.28139999508857727},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.2768999934196472},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.25920000672340393}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.64898/2026.09.21.751493","doi":"https://doi.org/10.64898/2026.09.21.751493","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.21.751493","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/27/2026.09.21.751493.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.64898/2026.09.21.751493","doi":"https://doi.org/10.64898/2026.09.21.751493","is_oa":true,"landing_page_url":"https://doi.org/10.64898/2026.09.21.751493","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2026/09/27/2026.09.21.751493.full.pdf","source":{"id":"https://openalex.org/S4306402567","display_name":"bioRxiv (Cold Spring Harbor Laboratory)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2750212522","host_organization_name":"Cold Spring Harbor Laboratory","host_organization_lineage":["https://openalex.org/I2750212522"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"bioRxiv","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[{"id":"https://openalex.org/G388162956","display_name":"Understanding the mechanisms of treatment resistance in colorectal cancer using organoid models","funder_award_id":"MR/X006433/1","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G5352452687","display_name":null,"funder_award_id":"23923","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320333939","display_name":"Imperial Experimental Cancer Medicine Centre","ror":null},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7214614276.pdf","grobid_xml":"https://content.openalex.org/works/W7214614276.grobid-xml"},"referenced_works_count":45,"referenced_works":["https://openalex.org/W1576237248","https://openalex.org/W1741548448","https://openalex.org/W1757407923","https://openalex.org/W1859257957","https://openalex.org/W1919257374","https://openalex.org/W1965157206","https://openalex.org/W2002513358","https://openalex.org/W2035252444","https://openalex.org/W2235737683","https://openalex.org/W2417483443","https://openalex.org/W2470575266","https://openalex.org/W2773293509","https://openalex.org/W2788735115","https://openalex.org/W2789816271","https://openalex.org/W2790038001","https://openalex.org/W2805379737","https://openalex.org/W2885650843","https://openalex.org/W2904971405","https://openalex.org/W2921113926","https://openalex.org/W2941549157","https://openalex.org/W2942656692","https://openalex.org/W2945647183","https://openalex.org/W2952509678","https://openalex.org/W2980113327","https://openalex.org/W2995460694","https://openalex.org/W3006653136","https://openalex.org/W3017323680","https://openalex.org/W3166391069","https://openalex.org/W4200048621","https://openalex.org/W4200519100","https://openalex.org/W4220677690","https://openalex.org/W4225318180","https://openalex.org/W4226088025","https://openalex.org/W4247053599","https://openalex.org/W4281878748","https://openalex.org/W4287510231","https://openalex.org/W4309412451","https://openalex.org/W4319826836","https://openalex.org/W4380989896","https://openalex.org/W4387872983","https://openalex.org/W4389951589","https://openalex.org/W4391231786","https://openalex.org/W4392200290","https://openalex.org/W4405003462","https://openalex.org/W7213925860"],"related_works":["https://openalex.org/W7213925860","https://openalex.org/W4411721063","https://openalex.org/W7207732226","https://openalex.org/W4393092216","https://openalex.org/W7117740679","https://openalex.org/W4381198676","https://openalex.org/W7148693498","https://openalex.org/W4318043427","https://openalex.org/W4393086699","https://openalex.org/W4362543702"],"abstract_inverted_index":{"ABSTRACT":[0],"Background":[1],"Colorectal":[2],"cancer":[3],"(CRC)":[4],"remains":[5],"a":[6,58,93,161,290,331],"leading":[7],"cause":[8],"of":[9,67,185,212,302,314,350],"cancer-related":[10],"mortality,":[11],"and":[12,28,51,56,81,105,118,129,137,148,160,177,205,228,234,253,280,321,347],"emerging":[13],"T":[14,90,101,112,140,152,164,173,192,202,277,303],"cell":[15,61,102,141,153,165,174,203,278,296,304],"engager":[16],"(TCE)":[17],"immunotherapies":[18],"require":[19],"predictive":[20],"preclinical":[21,348],"models":[22,147,216,223,252],"that":[23,48,167],"capture":[24],"patient-specific":[25],"tumour":[26,200,257,315],"biology":[27],"tumour-immune":[29,322],"interactions.":[30],"Although":[31],"patient-derived":[32,71,307],"organoid":[33,146,169,215,282],"(PDO)-immune":[34],"co-culture":[35,62,184,297],"systems":[36],"show":[37],"promise":[38],"for":[39,64,194,299,334],"evaluating":[40],"immunotherapy":[41,335],"responses,":[42,320],"many":[43],"rely":[44],"on":[45],"matrix-embedded":[46],"cultures":[47],"limit":[49],"scalability":[50],"reproducibility.":[52],"We":[53,288],"therefore":[54],"developed":[55],"validated":[57],"low-matrix":[59,95,294],"organoid-T":[60,295],"platform":[63,132,298,338],"functional":[65,230,300],"assessment":[66,313],"TCE":[68,231,285],"activity":[69],"in":[70,92,259,306],"CRC":[72,76,145,214,308],"models.":[73,309],"Methods":[74],"Patient-derived":[75],"organoids":[77,188],"representing":[78],"diverse":[79],"molecular":[80],"genetic":[82],"backgrounds":[83],"were":[84,108,120,266],"co-cultured":[85],"with":[86,189,221,241],"activated":[87,191],"allogeneic":[88],"CD3+":[89],"cells":[91,113,193],"suspension":[94],"format.":[96],"Matrix":[97],"concentration,":[98],"medium":[99,166],"composition,":[100],"activation":[103],"status,":[104],"assay":[106],"duration":[107],"optimized.":[109],"Tumour":[110],"killing,":[111,201,316],"activation,":[114,176,204,318],"cytokine":[115,127,271,319],"secretion,":[116],"apoptosis,":[117],"motility":[119],"assessed":[121],"using":[122,135],"flow":[123],"cytometry,":[124],"live-cell":[125],"imaging,":[126],"profiling,":[128],"immunofluorescence.":[130],"The":[131,179,337],"was":[133],"evaluated":[134],"EGFR-":[136,233],"HER2-targeting":[138,235],"bispecific":[139],"engagers":[142,305],"across":[143,208,250],"21":[144,213],"multiple":[149],"healthy":[150],"donor-derived":[151],"populations.":[154],"Results":[155],"Optimization":[156],"identified":[157],"1%":[158],"matrix":[159],"1:1":[162],"organoid:":[163],"preserved":[168],"integrity":[170],"while":[171,324],"maintaining":[172,224],"viability,":[175],"motility.":[178],"final":[180],"workflow":[181],"enabled":[182],"reproducible":[183],"5-day":[186],"mature":[187],"7-day":[190],"72":[195],"hours.":[196],"EGFR-targeting":[197],"TCEs":[198,236],"induced":[199],"IFN-\u03b3":[206],"secretion":[207],"donor-organoid":[209],"combinations.":[210],"Screening":[211],"revealed":[217],"substantial":[218],"inter-patient":[219,326],"heterogeneity,":[220,327],"12":[222],"\u226550%":[225],"baseline":[226],"viability":[227],"supporting":[229],"evaluation.":[232],"produced":[237],"potent":[238],"dose-dependent":[239],"cytotoxicity,":[240],"IC50":[242],"values":[243],"ranging":[244],"from":[245],"0.0188":[246],"to":[247,255],"54.77":[248],"nM":[249],"responsive":[251],"up":[254],"75%-85%":[256],"killing":[258],"the":[260],"most":[261],"sensitive":[262],"organoids.":[263],"These":[264],"responses":[265],"accompanied":[267],"by":[268],"increased":[269],"effector":[270],"secretion.":[272],"Real-time":[273],"imaging":[274],"confirmed":[275],"dynamic":[276],"engagement":[279],"apoptosis-driven":[281],"destruction":[283],"following":[284],"treatment.":[286],"Conclusions":[287],"establish":[289],"robust,":[291],"scalable,":[292],"human-relevant":[293],"screening":[301],"By":[310],"enabling":[311],"integrated":[312],"immune":[317],"interactions":[323],"preserving":[325],"this":[328],"system":[329],"provides":[330],"translational":[332],"framework":[333],"development.":[336],"may":[339],"support":[340],"candidate":[341],"prioritisation,":[342],"biomarker":[343],"discovery,":[344],"patient":[345],"stratification,":[346],"evaluation":[349],"immune-engaging":[351],"therapeutics.":[352]},"counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-09-29T00:00:00"}